RxDoctor Payments Data

Douglas Peters, MD

Family Medicine · West Burlington, IANPI 1528134343

Payments from drug & device makers

$257in general payments, 2019–2025

Across 19 payments — averaging $13.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$50
  • Pfizer$42
  • AbbVie$40
  • Teva Pharmaceuticals USA, Inc.$36
  • Novo Nordisk$27
  • Amgen$14
  • plus $48 from 4 others

What the payments were for

  • Food & beverage$257100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$257 in reported general payments places this provider in the 60th percentile of 1,357 family medicine providers in Iowa.

See all family medicine providers in Iowa

Medicare billing

Part B allowed, 2024
$124,613
Medicare patients
465
Services billed
1,582

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban90$128,341
JardianceEmpagliflozin94$117,738
OzempicSemaglutide58$67,395
FarxigaDapagliflozin Propanediol41$34,414
XareltoRivaroxaban38$25,640
MyrbetriqMirabegron38$18,093
Spiriva RespimatTiotropium Bromide14$14,974
Trelegy ElliptaFluticasone/Umeclidin/Vilanter20$12,902
JanuviaSitagliptin Phosphate16$11,868
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog25$10,596
Lantus SolostarInsulin Glargine,hum.Rec.Anlog74$10,268
Breo ElliptaFluticasone/Vilanterol14$9,069
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr11$8,371
Incruse ElliptaUmeclidinium Bromide13$7,135
Atorvastatin Calcium802$6,226

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Spiriva Respimat$11$132,711108 claims
PfizerEliquis$42$128,34190 claims
Novo NordiskOzempic$27$67,39558 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 1,357 family medicine providers in Iowa.

Other family medicine in West Burlington

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →